schizophrenia

ATAI Life Science, a Peter Thiel-backed start-up, has taken a majority stake in Recognify, a company that is developing drugs to help treat schizophrenia.

Jan 16 2021

Uncategorized

Parkinson’s disease may up schizophrenia risk: Study

by Clinical Editor

No Comments

Patients with a schizophrenia spectrum disorder have an increased risk of Parkinson’s disease later in life. The study indicates that the increased risk may be due to alterations in the...

Jan 16 2021

Uncategorized

Increased risk of Parkinson’s disease in patients with schizophrenia

by Clinical Editor

No Comments

A new study conducted at the University of Turku, Finland, shows that patients with a schizophrenia spectrum disorder have an increased risk of Parkinson’s disease later in life. The increased...

Jan 16 2021

Uncategorized

Schizophrenia- a deadly disease

by Clinical Editor

No Comments

HEALTHWISEThe world has expanded discussions about mental health. The mental well-being of a human is as necessary as physical well-being, and the world seems to realize it since we have...

Jan 16 2021

Uncategorized

Psychiatric Nurses’ Perceptions of Therapeutic Alliance With the Schizophrenia Population: A Survey Study

by Clinical Editor

No Comments

Research on nurse–patient relationships with the schizophrenia population is sparse. The current study piloted a survey to explore therapeutic relationships. Fifty-one psychiatric nurses completed an …